<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(5)</volume><submitter>Ingles-Esteve J</submitter><pubmed_abstract>14-3-3σ is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3σ in the termination of NF-κB signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3σ regulates nuclear export of p65-NF-κB following chronic TNFα stimulation. Restoration of 14-3-3σ in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNFα in a 14-3-3σ-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that over-expression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-κB activation strictly correlates with the absence of 14-3-3σ and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-κB targeting.</pubmed_abstract><journal>PloS one</journal><pagination>e38347</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3364992</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.</pubmed_title><pmcid>PMC3364992</pmcid><pubmed_authors>Albanell J</pubmed_authors><pubmed_authors>Espinosa L</pubmed_authors><pubmed_authors>Ruiz-Herguido C</pubmed_authors><pubmed_authors>Iglesias M</pubmed_authors><pubmed_authors>Rovira A</pubmed_authors><pubmed_authors>Jene-Sanz A</pubmed_authors><pubmed_authors>Ingles-Esteve J</pubmed_authors><pubmed_authors>Lopez-Bigas N</pubmed_authors><pubmed_authors>Gomis RR</pubmed_authors><pubmed_authors>Bigas A</pubmed_authors><pubmed_authors>Morales M</pubmed_authors><pubmed_authors>Rojo F</pubmed_authors><pubmed_authors>Garcia-Carbonell R</pubmed_authors><pubmed_authors>Dalmases A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.</name><description>14-3-3σ is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3σ in the termination of NF-κB signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3σ regulates nuclear export of p65-NF-κB following chronic TNFα stimulation. Restoration of 14-3-3σ in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNFα in a 14-3-3σ-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that over-expression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-κB activation strictly correlates with the absence of 14-3-3σ and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-κB targeting.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2026-04-07T20:09:59.043Z</modification><creation>2026-04-07T17:26:24.347Z</creation></dates><accession>S-EPMC3364992</accession><cross_references><pubmed>22675457</pubmed><doi>10.1371/journal.pone.0038347</doi></cross_references></HashMap>